HomeNewsStudy: Broad Anti-Smoking Vaccination Not Worth the Cost
March 6, 2012 A vaccination campaign to prevent teenagers from taking up smoking would be too expensive to recommend, according to Australian researchers who looked at the costs and benefits of anti-nicotine shots in development. No anti-smoking vaccines are on the market yet, but several have been tested in humans and there is considerable interest developing vaccines to reduce smoking rates and prevent youths from becoming smokers in the first place. Taking into account the effectiveness of the experimental vaccines designed to help smokers quit, researchers concluded that the drugs would need to be cheaper, require fewer doses, and get better results for widespread preventive vaccination of teens to be worthwhile. Lead Researcher Coral Gartner said that based on her results, a smoking vaccination program for teens is unlikely to receive public funding. “Rather than seeking technological fixes like preventive vaccination, we should focus on strategies that have greater potential to discourage smoking uptake and encourage quitting,” she said.
For More Information:
http://www.reuters.com/article/2012/03/02/us-anti-smoking-vaccination-idUSTRE8211I720120302
Report: Tobacco Companies and Convenience Stores Partner to Market Tobacco Products
Read the full story Mar 06, 2012
Obama Administration Appeals Ruling on Tobacco Graphic Warning Labels
Read the full story Mar 06, 2012
Study: Broad Anti-Smoking Vaccination Not Worth the Cost
Read the full story Mar 05, 2012
Smokeless Tobacco Use By Miami Teens Up 69 Percent: Study
Read the full story
Complete the form below to subscribe to the ActionToQuit listserv. Join the conversation about tobacco control policy and receive weekly updates.
Subscribe to the RSS feed to get notification of key dates.